Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-023626
Filing Date
2014-04-18
Accepted
2014-04-18 17:01:12
Documents
1
Period of Report
2014-04-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v369973_4.html 4  
1 OWNERSHIP DOCUMENT v369973_4.xml 4 3960
  Complete submission text file 0001144204-14-023626.txt   5480
Mailing Address C/O MEDGENICS, INC. 435 DEVON PARK DRIVE, BLDG 700 WAYNE PA 19087
Business Address C/O MEDGENICS, INC. 435 DEVON PARK DRIVE, BLDG 700 WAYNE PA 19087 1-646-239-1690
MEDGENICS, INC. (Issuer) CIK: 0001138776 (see all company filings)

EIN.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 8000 TOWERS CRESCENT DR. SUITE 1300 VIENNA VA 22182
Business Address
Bellin Phyllis K. (Reporting) CIK: 0001516546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35112 | Film No.: 14772428